Related Experiment Video

Updated: Jun 22, 2026

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting
08:14

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

Cancer stem cells in pediatric brain tumors

Joseph L Lasky1, Meeryo Choe, Ichiro Nakano

  • 1Department of Neurosurgery, David Geffen School of Medicine at UCLA, USA.

Current Stem Cell Research & Therapy
|June 9, 2009
PubMed

Insights

Pediatric brain tumors are a leading cause of cancer death in children. Identifying and targeting brain tumor stem cells (BTSC) offers a promising strategy for developing more effective and less toxic treatments for these devastating CNS neoplasms.

Area of Science:

  • Pediatric oncology
  • Neuro-oncology
  • Cancer stem cell biology

Background:

  • Central nervous system (CNS) tumors are the primary cause of cancer-related death in children.
  • Standard therapies for pediatric CNS tumors can lead to severe long-term cognitive and physical deficits.
  • Recurrent pediatric brain tumors have a poor prognosis, highlighting the need for novel therapeutic approaches.

Purpose of the Study:

  • To review the identification and characterization of brain tumor stem cells (BTSC) in pediatric brain tumors.
  • To discuss the molecular biology of BTSC in various pediatric CNS neoplasms.
  • To explore future therapeutic strategies targeting BTSC for improved patient outcomes.

Main Methods:

  • Literature review focusing on recent investigations into brain tumor stem cells.
  • Analysis of molecular mechanisms underlying pediatric brain tumor initiation and progression.
  • Comparison of adult glioblastoma multiforme with pediatric brain tumors.

Main Results:

  • Brain tumor stem cells (BTSC) have been identified in heterogeneous cell populations of malignant pediatric brain tumors, including medulloblastoma, ependymomas, and malignant gliomas.
  • BTSC are implicated in therapeutic resistance to current standard treatments.
  • Molecular differences within tumor cell populations may be exploitable for targeted therapies.

Conclusions:

  • Targeting BTSC holds potential for specific eradication of tumor cells, leading to long-lasting remissions.
  • Exploiting molecular distinctions in BTSC could reduce toxicity to normal tissues compared to conventional therapies.
  • Further research into BTSC biology is crucial for developing innovative treatments for pediatric CNS tumors.

More Related Videos

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens09:26

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens

Published on: July 29, 2011

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

Related Concept Videos

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...